| Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A-R | USD | 223.000 | - | Aaa | AAA | - | - | - | - | - | Floating | 3mL | - | - | 3mL+127 | - | - |
| B-1R | USD | 22.000 | - | - | AA | - | - | - | - | - | Floating | 3mL | - | - | 3mL+190 | - | - |
| B-2R | USD | 22.000 | - | - | AA | - | - | - | - | - | Floating | 3mL | - | - | 3mL+190 | - | - |
| C-R | USD | 18.500 | - | - | A | - | - | - | - | - | Floating | 3mL | - | - | 3mL+280 | - | - |
| D-R | USD | 17.500 | - | - | BBB | - | - | - | - | - | Floating | 3mL | - | - | 3mL+380 | - | - |
| E-R | USD | 18.000 | - | - | BB- | - | - | - | - | - | Floating | 3mL | - | - | 3mL+550 | - | - |
| Jr Equity | USD | 29.950 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Sr Equity | USD | 7.250 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Explore all other research.